First-in-human Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Doses of CC-90001
Clinical trial NCT02110420 · COMPLETED
Trial details
- NCT number
- NCT02110420
- Sponsor
- Celgene Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2014-09-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.